journal
MENU ▼
Read by QxMD icon Read
search

Therapeutic Apheresis and Dialysis

journal
https://www.readbyqxmd.com/read/27921376/diagnostic-accuracy-of-serum-cystatin-c-for-the-evaluation-of-renal-dysfunction-in-diabetic-patients-a-meta-analysis
#1
Shi-Kun Yang, Jun Liu, Xian-Ming Zhang, Chun Hu, Wei Zhang, Lin Sun, Hao Zhang
This study aimed to evaluate the diagnostic value of serum cystatin C for renal dysfunction in diabetic patients. Eligible trials were searched from multiple databases, the data were extracted into a 2 × 2 table after the quality assessment of included articles. The pooled sensitivity, specificity and other parameters of accuracy of cystatin C were analyzed using Stata version 12.0. Seventeen studies involving 2173 patients were included. The pooled sensitivity and specificity of serum cystatin C for the diagnosis of renal dysfunction were 0...
December 6, 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27921374/efficacy-of-a-novel-granulocyte-monocyte-apheresis-adsorber-device-in-the-treatment-of-inflammatory-bowel-diseases-a-pilot-study
#2
Maria Di Girolamo, Alessandro Sartini, Rosina Critelli, Angela Bertani, Alberto Merighi, Erica Villa
Granulocyte monocyte apheresis (GMA) is a non-pharmacological treatment for inflammatory bowel disease. In our study, we tested a novel GMA adsorber device in terms of clinical efficacy and safety in patients' non-response to pharmacological therapy. Secondary outcomes were the evaluation of adsorber's technical performance, the reduction of inflammatory markers and the improvement of patients' life quality. The prospective study included 18 patients enrolled from 2011 to 2012 with a monitoring of 48 weeks...
December 5, 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27897386/cardiovascular-and-stroke-risk-in-japanese-hemodialysis-patients-with-atrial-fibrillation
#3
Jumpei Hasegawa, Brian Bieber, Maria Larkina, Bruce M Robinson, Sachiko Wakai, Tadao Akizawa, Akira Saito, Shunichi Fukuhara, Takashi Akiba
Atrial fibrillation is one of the most common arrhythmias in hemodialysis patients. We evaluated its clinical outcomes among hemodialysis patients with atrial fibrillation in Japan. Using data derived from the Japanese Dialysis Outcomes and Practice Patterns Study, we analyzed backgrounds and outcomes among hemodialysis patients with and without atrial fibrillation in Japan. Among 7002 hemodialysis patients, the prevalence of atrial fibrillation was 5.7% and the incidence was 0.2 per 100 patient-years. Atrial fibrillation was independently associated with all-cause mortality (hazard ratio, 1...
November 29, 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27896908/bixalomer-in-hyperphosphatemic-patients-with-chronic-kidney-disease-not-on-dialysis-phase-3-randomized-trial
#4
Tadao Akizawa, Hideki Origasa, Chisato Kameoka, Junko Tsukada, Kentarou Kuroishi, Yusuke Yamaguchi
Currently, calcium- or metal-containing phosphate binders are available to treat hyperphosphatemia in predialysis patients with chronic kidney disease. Bixalomer, a non-calcium, metal-free phosphate binder, has not been studied in these patients. We evaluated the efficacy and safety of bixalomer versus placebo for treatment of hyperphosphatemia in Japanese predialysis patients with chronic kidney disease. This multicenter, randomized, double-blind, phase 3 trial, randomized eligible patients 1:1 to receive bixalomer or placebo for 12 weeks...
November 29, 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27787966/triceps-skinfold-thickness-is-associated-with-lumbar-bone-mineral-density-in-peritoneal-dialysis-patients
#5
Yu-Li Lin, Yu-Hsien Lai, Chih-Hsien Wang, Chiu-Huang Kuo, Hung-Hsiang Liou, Bang-Gee Hsu
Anthropometric measurements, including body mass index (BMI), body weight and total fat mass are associated with the bone mineral density (BMD) in the general population. Compared to that in the general population, BMD was lower in dialysis patients. However, the association between anthropometric measurements and BMD is not well-established among peritoneal dialysis (PD) patients. To study this, we conducted a cross-sectional study in 48 chronic PD patients. Anthropometric parameters, biochemical data, and BMD measured by dual energy X-ray absorptiometry in lumbar vertebrae (L2-L4) were collected...
October 27, 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27786420/outcomes-of-continuous-renal-replacement-therapy-with-regional-citrate-anticoagulation-in-small-children-after-cardiac-surgery-experience-and-protocol-from-a-single-center
#6
Anna Musielak, Alfred Warzywoda, Michał Wojtalik, Bartłomiej Kociński, Paweł Kroll, Danuta Ostalska-Nowicka, Jacek Zachwieja
Patients after a cardiac surgery in cardiopulmonary bypass often present an acute kidney failure. Continuous renal replacement therapy (CRRT) is often required. The aim of this study was to present effectiveness and safety of CRRT with regional citrate anticoagulation (RCA-CRRT) in small children after cardiac surgery. A retrospective analysis was conducted on 15 patients after cardiac surgery and who had RCA-CRRT performed in 2014. The established protocol was followed. Mean time on the RCA-CRRT was 192 h 40 min with the circuit mean lifetime of 43 h 33 min...
October 27, 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27786418/is-efficacy-of-the-anti-cd20-antibody-rituximab-preventing-hemolysis-due-to-passenger-lymphocyte-syndrome
#7
Kazuma Tsujimura, Hideki Ishida, Kazunari Tanabe
Passenger lymphocyte syndrome (PLS) often occurs after ABO-mismatched solid organ and/or bone marrow transplantation between a donor and recipient. Viable donor B-lymphocytes transferred during organ transplantation produce antibodies against recipient red cell antigens, leading to hemolysis. The incidence of PLS has been reported to be around 9% after renal transplantation. A previous report showed that rituximab (Rit) was useful for treatment of PLS in allogeneic stem cell transplantation, bowel transplant and severe cases of hemolysis...
October 27, 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27786416/does-guidewire-exchange-influence-infection-rate-related-to-catheters-used-for-vascular-access-in-children-on-chronic-hemodialysis
#8
Rina R Rus, Nina Battelino, Rafael Ponikvar, Vladimir Premru, Gregor Novljan
A central venous catheter (CVC) can either be inserted "de novo" or placed by guidewire exchange (GWE). From September 1998 to September 2015, 32 children (19 boys, 13 girls) were hemodialyzed in our unit by using a CVC. The mean age at CVC insertion was 12.6 ± 0.5 years. A total of 121 uncuffed catheters were placed, either "de novo" or by GWE in 64 (52.9%) and 57 (47.1%) cases, respectively. The most frequent cause for line revision was catheter dysfunction in 40/121 (33.1%) patients. The overall incidence of bacteremia was 1...
October 27, 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27629941/dialyzability-of-faropenem-in-infected-patients-on-chronic-hemodialysis
#9
Gohki Hasegawa, Shuichi Tsuruoka, Kentaro Ushijima, Akimitsu Maeda, Tokie Hayasaka, Tetsuo Saito, Kazuhiro Harada, Akio Fujimura
The aim of this study was to evaluate the profile of dialyzability of an oral penem antibiotic, faropenem (FRPM), in hemodialysis (HD) patients with infections. Eight patients took one tablet of FRPM (200 mg) every 12 h during an inter-dialysis period, and another tablet at 1-5 h before the beginning of the HD session. Blood samples were obtained during the HD session (3-4 h). Plasma FRPM concentrations in the arterial side were 4.8 ± 2.5 and 2.8 ± 1.0 µg/mL before and at the end of HD session, respectively, which are above the 50% minimal inhibitory concentrations of FRPM against the major pathogen (0...
September 15, 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27629817/albumin-dialysis-as-a-bridge-from-total-hepatectomy-to-liver-transplantation-for-fulminant-hepatitis-with-toxic-syndrome
#10
Eric Levesque, Daniel Azoulay, Cyrille Feray, Gilles Dhonneur
No abstract text is available yet for this article.
September 15, 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27629694/legionella-pneumophila-a-renal-vasculitis-trigger
#11
Diego Coronel, Ana Armesto, Secundino Cigarrán, Jesus Calviño
No abstract text is available yet for this article.
September 15, 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27620210/effect-of-scavenging-circulating-reactive-carbonyls-by-oral-pyridoxamine-in-uremic-rats-on-peritoneal-dialysis
#12
Yoshitaka Mori, Takatoshi Kakuta, Takayo Miyakogawa, Susumu Takekoshi, Hiroko Yuzawa, Hiroyuki Kobayashi, Atsushi Kawakami, Toshio Miyata, Masafumi Fukagawa
Pyridoxamine, a reactive carbonyl (RCO) scavenger, can ameliorate peritoneal deterioration in uremic peritoneal dialysis (PD) rats when given via dialysate. We examined the effects of scavenging circulating RCOs by oral pyridoxamine. Rats underwent nephrectomy and 3 weeks of twice daily PD either alone or with once daily oral pyridoxamine. PD solution was supplemented with methylglyoxal, a major glucose-derived RCO, to quench intraperitoneal pyridoxamine. Oral pyridoxamine achieved comparable blood and dialysate pyridoxamine concentrations, suppressed pentosidine accumulation in the blood but not in the mesenterium or dialysate, and reduced the increases in small solute transport and mesenteric vessel densities, with no effects on submesothelial matrix layer thickening or serum creatinine...
September 13, 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27753277/the-isfa-wishes-to-acknowledge-the-following-2016-corporate-sponsors
#13
(no author information available yet)
No abstract text is available yet for this article.
October 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27753276/upcoming-meetings
#14
(no author information available yet)
No abstract text is available yet for this article.
October 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27753275/message-from-the-new-president-of-the-japanese-society-for-dialysis-therapy
#15
Hidetomo Nakamoto
No abstract text is available yet for this article.
October 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27753274/corrigendum
#16
(no author information available yet)
No abstract text is available yet for this article.
October 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27753273/abstracts
#17
Bernd Hohenstein
As a major event in the field of therapeutic apheresis, lipidology and immune-modulating extracorporeal treatments, Dresden hosted the 4(th) International Symposium on Therapeutic Apheresis 17-19 March 2016. In conjunction with the newly founded European Group - International Society for Apheresis, this meeting attracted more than 300 clinicians and scientists from more than a dozen European countries and further developed into an important event for participants, industry and nursing staff. Due to the relevant role of lipoprotein apheresis in Germany and the recent launch of PCSK9 inhibitors corresponding sessions, the symposium reflected all aspects of this new lipidological therapy in a number of sessions...
October 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27641231/hypovolemic-shock-after-starting-hemodialysis-due-to-malposition-of-femoral-double-lumen-catheter
#18
Shang-Feng Tsai, Jun-Li Tsai
No abstract text is available yet for this article.
October 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27633509/did-lanthanum-carbonate-improve-prognosis-in-patients-requiring-chronic-hemodialysis-in-the-kawashima-study
#19
Yoshinari Oka, Hiroaki Matsuda, Masashi Miyazaki
No abstract text is available yet for this article.
October 2016: Therapeutic Apheresis and Dialysis
https://www.readbyqxmd.com/read/27633388/therapeutic-apheresis-in-hematologic-autoimmune-and-dermatologic-diseases-with-immunologic-origin
#20
Rolf Bambauer, Reinhard Latza, Daniel Burgard, Ralf Schiel
The process of curing a patient by removing his illness by extracting blood is a very old one. Many years ago, phlebotomy was practiced to cure illness. Now, this old process, placed on a rational basis with therapeutic apheresis (TA), is being followed in clinical practice. Therapeutic plasma exchange (TPE) with hollow fiber modules has been used in different severe diseases for more than 40 years. Based on many years of experience with the extracorporeal circulation in end-stage renal disease, the authors herein give an overview of TA in immunological diseases, especially in hematologic, autoimmune and dermatologic diseases...
October 2016: Therapeutic Apheresis and Dialysis
journal
journal
40470
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"